Condensed Statement of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from Operating Activities:
Net loss	$ (220,264)	$ (2,585,255)
Adjustments to reconcile net loss to net cash used in operating activities:
(Gain) loss on warrant liabilities	(3,878,572)	912,766
Offering costs attributable to warrant liabilities		6,835
Interest earned on marketable securities held in Trust Account	(823,607)	(54,504)
Unrealized (gain) loss on marketable securities held in Trust Account	(983,987)	17,547
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	163,808	(357,624)
Related party payable	388,959
Accrued expenses	4,851,606	1,060,872
Net cash used in operating activities	(502,057)	(999,363)
Cash flows from Investing Activities:
Investment in trust account		(258,750,000)
Withdrawals from Trust Account	421,391
Net cash provided by (used in) investing activities	421,391	(258,750,000)
Cash flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid		253,575,000
Proceeds from sale of Private Placement Warrants		6,925,000
Proceeds from promissory note – related party		149,476
Repayment of promissory note – related party		(149,476)
Payment of offering costs		(502,651)
Net cash provided by financing activities		259,997,349
Net Change in Cash	(80,666)	247,986
Cash – Beginning of period	120,785
Cash – End of period	40,119	247,986
Non-Cash investing and financing activities:
Offering costs paid by Sponsor in exchange for issuance of Founder Shares		25,000
Issuance of Representative Shares		20
Remeasurement in value of common stock subject to redemption	$ (1,142,679)	$ (36,957)